[1] |
LI Min, LI Chunlei, SUN Cuicui, YU Wenwen, SUN Qing, QI Yingmei, LIU Anchang.
One Case of Acute Generalized Exanthematous Pustulosis Caused by Abrocitinib Tablets
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 823-825.
|
[2] |
JI Qiuxia, JIN Jian, ZHANG Bin.
Pharmaceutical care for immune-related adverse events induced by toripalimab
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(3): 346-348.
|
[3] |
GUO Yijun, CHEN Xia, MENG Ping.
Adverse drug reaction reports in 141 cases of orally administered targeted anti-tumor drugs
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(10): 1137-1142.
|
[4] |
SHI Xiangfen, SUN Zhiyong, ZHANG Xufeng, LU Xiaojing, DU Shuzhang, ZHANG Xiaojian.
Whole process management of narcotic drugs and psychotropic drugs based on intelligent information management system
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 899-903.
|
[5] |
HUO Yanfei, TIAN Yuejie, XU Lili, XIE Yanjun, CHANG Hong, SUN Chunxiao, LI Xia.
535 reports of new and serious adverse drug reactions caused by preparations of lappaconitine hydrobromide
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 921-926.
|
[6] |
ZHENG Yujing, ZHAO Zinan, JIN Pengfei, ZHAO Fei, HU Xin, ZHANG Yatong.
Active monitoring of adverse reactions of capecitabine-induced hand-foot syndrome based on the hospital information system
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(4): 441-443.
|
[7] |
SU Xinxin, ZHAO Xiaoxiao, XIE Yanming.
Real-world analysis of combined administration of elemene emulsion injection in patients with liver cancer
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(9): 929-934.
|
[8] |
HUANG Yanli, XIE Yanming, WANG Lianxin, SUN Linxi, LIU Huan, ZHUANG Yunni.
Clinical applications of Ciwujia injection in elderly patients in the real world
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(9): 935-939.
|
[9] |
ZHUANG Hongyan, ZANG Yannan, LIU Shanshan, NIU Mengxi, FANG Meng, YIN Dongqing, GUO Wei.
Analysis of neuropsychiatric adverse reactions caused by zolpidem
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(8): 889-892.
|
[10] |
SUN Chunquan, XIE Yanming, HOU Hengyue.
Data mining of clinical characteristics and combined medications of 4 832 patients with heart failure treated with Shengmai injection
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(2): 130-133.
|
[11] |
SUN Chunquan, XIE Yanming, HOU Hengyue.
Clinical characteristics and combined medication of Shengmai injection in the treatment of 9215 elderly patients with cardiovascular diseases
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(1): 36-40.
|
[12] |
CHENG Fengjingming, XIE Yanming, WANG Lianxin, MIAO Yu.
Effect of Mailuoshutong Pills on Renal Function Indexes in the Real World Based on Propensity Scores
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(6): 537-541.
|
[13] |
ZHOU Hong, JIN Hongchang, QIN Jinfeng, ZHAO Feiyu, HE Renxian, XIE Lixia, TIAN Xiaodong.
Establishment and Application of Intelligent Reporting System for Adverse Drug Reactions in Hospitals
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(2): 93-97.
|
[14] |
LYU Tianyi, KUANG Li, CHEN Mingying.
Analysis of 1073 Cases of Clinical Use of Reduning Injection by Pareto Chart and Fishbone Diagram
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(10): 745-748.
|
[15] |
XU Shungui.
105 Cases of Adverse Drug Reactions Indcued by Ibuprofen in Our Hosptial
[J]. Chinese Journal of Pharmacovigilance, 2019, 16(3): 164-167.
|